ArticleOncoTargets and therapy2019

Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?

Yun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.